Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
71.00
-0.87%
After-hours: Aug 15, 2025, 06:52 PM EDT

Soleno Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-175.85M -38.99M -24.07M -30.91M
Depreciation & Amortization
1.99M 1.96M 1.96M 1.96M
Stock-Based Compensation
99.96M 5.95M 2.53M 3.28M
Other Working Capital
346K 1.56M 721K -913K
Other Non-Cash Items
-1.21M 3.22M -452K -443K
Deferred Income Tax
n/a n/a n/a -508K
Change in Working Capital
6.02M 2.93M -756K -1.15M
Operating Cash Flow
-69.1M -24.94M -20.78M -27.77M
Capital Expenditures
-218K n/a -13K -22K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-356.46M n/a n/a n/a
Sales Maturities Of Investments
131M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-225.68M n/a -13K -22K
Debt Repayment
49.89M n/a n/a -8K
Common Stock Repurchased
n/a n/a n/a -120
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
14.18M 42.16M -16K -120K
Financial Cash Flow
213.03M 180.02M 14.09M -128K
Net Cash Flow
-81.75M 155.08M -6.7M -27.92M
Free Cash Flow
-69.31M -24.94M -20.79M -27.79M